[A dose-response meta-analysis on the relationship between daily tea intake and cardiovascular mortality based on the
1Department of Pharmacy, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Insights
Drinking tea daily is linked to lower cardiovascular disease (CVD) mortality. This meta-analysis suggests that regular tea consumption, particularly green tea, offers protective benefits against CVD deaths.
Area of Science:
- Cardiovascular Health
- Nutritional Epidemiology
- Preventive Medicine
Background:
- Cardiovascular diseases (CVD) remain a leading cause of mortality worldwide.
- Lifestyle factors, including dietary habits, play a crucial role in CVD prevention.
- The potential health benefits of tea consumption have been investigated, but conclusive evidence on its impact on CVD mortality is needed.
Purpose of the Study:
- To conduct a comprehensive meta-analysis exploring the association between daily tea intake and cardiovascular disease (CVD) mortality.
- To evaluate the dose-response relationship between tea consumption and CVD mortality.
- To identify potential differences in this association across various populations and tea types.
Main Methods:
- A systematic search of multiple databases (PubMed, EMbase, Cochrane, etc.) was performed up to June 2020.
- Included 21 cohort or case-control studies with over 1.3 million participants and reported 38,222 CVD deaths.
- Utilized dose-response meta-analysis, sensitivity analysis, publication bias assessment, and GRADE methodology for quality evaluation.
Main Results:
- Increased daily tea intake showed a non-linear inverse relationship with CVD mortality, with each additional cup reducing mortality by approximately 3%.
- Drinking 1-8 cups of tea daily was associated with an 8-16% reduction in CVD mortality compared to non-drinkers.
- Subgroup analyses indicated significant reductions in CVD mortality for men, women, Asians, and green tea drinkers, with non-smokers showing the most pronounced benefit.
Conclusions:
- Daily tea consumption is significantly associated with reduced cardiovascular disease mortality.
- An appropriate daily intake of tea, particularly green tea, is recommended for cardiovascular health benefits.
- While evidence suggests benefits, the GRADE assessment indicated low-grade evidence, warranting further high-quality research.
Abstract:
Objective: To explore the relationship between daily tea intake and cardiovascular disease (CVD) mortality. Methods: PubMed, EMbase, The Cochrane, Chinese Biomedical Literature Database, CNKI, and Wanfang Database were searched to collect research on tea intake and CVD mortality. The search period was from the establishment of the database to June 2020. Two researchers independently screened and extracted literature. The risk of bias was evaluated in the included studies, a dose-response meta-analysis was conducted, sensitivity analysis and publication bias analysis of the research results, and quality evaluation of the included literature and GRADE classification of the evidence body were performed. Results: A total of 21 cohort or case-control studies were included, including 1 304 978 subjects. Among them, 38 222 deaths from CVD were reported. The quality scores of the included studies were all ≥ 6 points. The dose-response meta-analysis showed that for every additional cup of tea intake per day, the mortality rate of CVD decreased by about 3% (95%CI 0.95-0.98, P<0.05), and there was a non-linear dose-response relationship (P<0.05). Compared with people who do not drink tea, people who drink 1 to 8 cups of tea a day have 8% lower CVD mortality (RR=0.92, 95%CI 0.89-0.95), 13% (RR=0.87, 95 %CI 0.84-0.91), 15% (RR=0.85, 95%CI 0.82-0.89), 15% (RR=0.85, 95%CI 0.81-0.89), 16% (RR=0.84, 95%CI 0.80-0.89), 16% (RR=0.84, 95%CI 0.81-0.88), 16% (RR=0.84, 95%CI 0.81-0.87), 16% (RR=0.84, 95%CI 0.80-0.88), respectively. The results of traditional meta-analysis showed that compared with people who do not drink tea, people who drink more than 1 cup of tea a day are associated with 14% lower CVD mortality rate (RR=0.86, 95%CI 0.81-0.91, I2=73.2%, P<0.05). The results of subgroup analysis showed that compared with the corresponding people who did not drink tea, men who drank more than 1 cup of tea a day reduced the CVD mortality rate by 24%, women by 14%, European and American populations by 12%, and Asian populations by 15%. The population who consumed green tea decreased CVD mortality by 15%, and the population of non-smokers decreased CVD mortality by 20% (all P<0.05). The population who consumed black tea decreased CVD mortality by 8%, and the smoking population who consumed black tea decreased CVD mortality by 3%, and the difference was not statistically significant (all P>0.05). The results of the bias analysis showed that Begg=0.42 and Egger=0.62, indicating that the distribution on both sides of the funnel chart is symmetrical, suggesting that there is no publication bias. The results of sensitivity analysis showed that the effect size of the outcome index did not change significantly after excluding any article, indicating that the results are robust and credible. The GRADE evaluation showed that the evidence grades of the outcome indicators were all low grade. Conclusions: Daily tea consumption is related to reduced CVD mortality. It is therefore recommended to drink an appropriate amount of tea daily.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Dose-Response Relationship: Overview
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Dose-Response Relationship: Potency and Efficacy
Hazard Ratio
For example, in a clinical trial...
